Genomic and experimental evidence that ALKATI does not predict single agent sensitivity to ALK inhibitors
Summary: Genomic data can facilitate personalized treatment decisions by enabling therapeutic hypotheses in individual patients. Mutual exclusivity has been an empirically useful signal for identifying activating mutations that respond to single agent targeted therapies. However, a low mutation freq...
Enregistré dans:
Auteurs principaux: | Haider Inam, Ivan Sokirniy, Yiyun Rao, Anushka Shah, Farnaz Naeemikia, Edward O'Brien, Cheng Dong, David M. McCandlish, Justin R. Pritchard |
---|---|
Format: | article |
Langue: | EN |
Publié: |
Elsevier
2021
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/f98a7049c703493fbae9b06d38862432 |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
- NPJ systems biology and applications
-
Thrombolytic Agents: Nanocarriers in Targeted Release
par: Minghua Shen, et autres
Publié: (2021) -
Logical and experimental modeling of cytokine and eicosanoid signaling in psoriatic keratinocytes
par: Eirini Tsirvouli, et autres
Publié: (2021) - Communications biology
-
An integrated multi-omic analysis of iPSC-derived motor neurons from C9ORF72 ALS patients
par: Jonathan Li, et autres
Publié: (2021)